SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001641640-18-000001
Filing Date
2018-07-27
Accepted
2018-07-27 16:10:23
Documents
1
Effectiveness Date
2018-07-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15542
  Complete submission text file 0001641640-18-000001.txt   16761
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-317965 | Film No.: 18974940
SIC: 2834 Pharmaceutical Preparations